Date:2/19/2010

g">University of Notre Dame, sees Bioscience Vaccines as an important opportunity for the ECM technology.  "While a pathogen protein approach makes vaccines purer, safer and quicker to produce, it also increases the need for adjuvants to ensure efficacy.  We believe that our ECM-based product can be formulated for use with vaccine products already being used for the prevention of specific human diseases.  There is also potential for the product to be used by the U.S. Department of Agriculture for the prevention of animal diseases."

"By having Bioscience Vaccines as an exclusive licensee, they will be able to focus their ECM research and development on the specialized area of vaccines," said Mark Bleyer, President, Cook Biotech and member of Bioscience Vaccines' Board of Directors.

The company is currently in discussions to locate its headquarters at Innovation Park at Notre Dame in South Bend, IN.

About BioCrossroads

BioCrossroads (w
'/>"/>

SOURCE BioCrossroads Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
2. Indiana Biopharmaceutical Service Providers Maintain Steady Growth Despite Industry Challenges
3. Indiana Industry, University and Community Leaders Capitalize on Next Generation of States Life Sciences Growth
4. Collaboration of Indianas Health Information Exchanges, State Organizations Submits Application for Health Information Technology Stimulus Funding
5. A New Economic Future for Rural Indiana?: Study to Show How Renewable Energy Could Trigger Boom for Economically Struggling Areas in State
6. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
7. Expanding Indianas Breakthroughs in Health Information Technology (Exibhit Indiana): Initiative to Advance the States Health IT National Leadership and Assets Launched to Bring More Awareness to Sector
8. Clarient Granted Exclusive License to Commercialize Breast Cancer Biomarker by Indiana University Research and Technology Corporation
9. Hoosiers Work for Health Highlights Impact of Medical Research and Innovation on Indiana Economy
10. Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
11. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy